Evidence map›Paper›PMID 30496705›Full record

Trial reportJournal of applied physiology (Bethesda, Md. : 1985)2019

Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight, middle-aged men.

Zainie Aboo Bakkar, Jonathan Fulford, Phillip E Gates, Sarah R Jackman, Andrew M Jones, Bert Bond, Joanna L Bowtell

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of applied physiology (Bethesda, Md. : 1985), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. The influence of tart cherries (Journal of nutritional science · 2021
    Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond.International journal of molecular sciences · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zainie Aboo BakkarSport and Health Sciences, University of Exeter , United Kingdom.
Jonathan FulfordUniversity of Exeter Medical School , United Kingdom.
Phillip E GatesUniversity of Exeter Medical School , United Kingdom.
Sarah R JackmanSport and Health Sciences, University of Exeter , United Kingdom.ORCID 0000-0003-2928-8266
Andrew M JonesSport and Health Sciences, University of Exeter , United Kingdom.
Bert BondSport and Health Sciences, University of Exeter , United Kingdom.
Joanna L BowtellSport and Health Sciences, University of Exeter , United Kingdom.
University of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoid supplementation improves brachial artery flow-mediated dilation (FMD), but it is not known whether flavonoids protect against vascular dysfunction induced by ischemia-reperfusion (IR) injury and associated respiratory burst. In a randomized, double-blind, placebo-controlled, crossover study, we investigated whether 4 wk supplementation with freeze-dried Montmorency cherry (MC) attenuated suppression of FMD after IR induced by prolonged forearm occlusion. Twelve physically inactive overweight, middle-aged men (52.8 ± 5.8 yr, BMI: 28.1 ± 5.3 kg/m

Indexed as

Dietary SupplementsPrunus aviumBrachial ArteryCross-Over StudiesDouble-Blind MethodEndothelium, VascularForearmHumansHypertensionMaleMiddle AgedOverweightPhytotherapyReperfusion InjuryVasodilationendothelial functionforearm occlusionMontmorency cherrynitrite/nitrateperoxiredoxin-2

Identifiers

PMID30496705
PMCPMC6383639
OpenAlexW2903071968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.